Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled Trial
Alexander Bertuccioli(University of Urbino), Davide Sisti(University of Urbino), Giordano Bruno Zonzini(University of Urbino), Marco Cardinali(University of Urbino), Marco Rocchi(University of Urbino), Giosuè Annibalini(University of Urbino), Matteo Micucci(University of Urbino), Annalisa Belli(University of Urbino), Chiara Maria Palazzi(International Society of Nephrology)
Cited by 8
Related Papers
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
|International Journal of General Medicine|2021|183
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
|International Journal of General Medicine|2021|177
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
|Frontiers in Pharmacology|2023|54
β-Arrestin1 and β-Arrestin2 Are Required to Support the Activity of the CXCL12/HMGB1 Heterocomplex on CXCR4
|Frontiers in Immunology|2020|37
Effects of Calcium and Vitamin Supplementation on Colon Cell Proliferation in Colorectal Cancer
|Cancer Investigation|2000|35